BPC-157

Price range: $49 through $55

5MG, 10MG

BPC-157 is dosed at 200 mcg–600 mcg daily via subcutaneous injection in educational protocols. A 10 mg vial reconstituted with bacteriostatic water yields about 3.33 mg/mL. This information is for research and educational use only.

In stock   |   ≥99% catalog purity

SKU: N/A Category:

Description

Product specification

Analytical Profile

Catalog data is presented for material identification and laboratory planning. Batch-specific documentation governs the supplied vial.

RESEARCH NAME BPC-157 · Bepecin · PL 14736
FORMAT Lyophilised powder · 5 mg vial
MOLECULAR FORMULA C209H322N54O64
MOLECULAR MASS 1419.54 g/mol
CAS REGISTRY 137525-51-0
ANALYTICAL IDENTITY HPLC + LC–MS
CATALOG CONDITION Sealed · dry · light-protected · −20°C

PROTOCOL LITERACY

Reconstitution Sequence

A designed reference covering concentration, weekly schedule models, reconstitution, supply planning, storage, mechanism, study observations, and administration context. It is educational material—not an individualized regimen.

01

Metabolic

Prepare 1.0 mL of bacteriostatic water with sterile equipment.

02

INTRODUCE SLOWLY

Direct the liquid toward the inside wall of the vial to limit foaming.

03

DISSOLVE GENTLY

Roll or swirl with care until the material is dissolved; do not shake.

04

LABEL AND PROTECT

Record the preparation date and keep the vial protected from light.

05

COLD STORAGE

Refrigerate at 2-8°C and use within the four-week reference window.

UNRECONSTITUTED MATERIAL

-20°C

Keep frozen, dry, sealed, and protected from direct light. Minimise exposure to moisture.

After reconstitution

2-8°C

Keep refrigerated and protected from light. Follow the applicable batch documentation.

Handling principle

DO NOT FREEZE

Allow the vial to reach room temperature before opening to reduce condensation. Avoid repeated freeze–thaw cycles.

PROTOCOL LITERACY

GRADUAL DAILY MODEL

A designed reference covering concentration, weekly schedule models, reconstitution, supply planning, storage, mechanism, study observations, and administration context. It is educational material—not an individualized regimen.

VIAL CONTENT

1.0 MG

+

REFERENCE DILUENT

1.0 MG

=

STOCK CONCENTRATION

1.0 MG/ML

U-100 SCALE

1 Unit = 0.01 ml 100 mcg

01

GRADUAL 8MG MODEL

02

12 MG TRIAL CONTEXT

EDUCATIONAL REFERENCE

GRADUAL DAILY MODEL

STUDY INTERVAL STAGE WEEKLY DOSE U-100 REFERENCE SOLUTION VOLUME
01 WEEKS 1-2
INITIATION 0.2 mg 20 UNITS 0.12 ML
02 WEEKS 3-4
ESCALATION 01 0.4 mg 24 UNITS 0.24 ML
03 Weeks 5–8+
INITIATION 0.6 mg 36 UNITS 0.36 ML

01

REFERENCE ASSUMPTIONS

Every unit and volume value shown assumes a 10 mg vial prepared to a total reference volume of 1.0 mL.

02

MATERIAL BOUNDARY

This table does not provide preparation or administration instructions.

03

PROTOCOL CONTROL

Trial documentation and qualified clinical oversight—not this chart—must govern all dosing decisions.

Product Enquiry

Have a question about this product? Send us your enquiry and our team will get back to you shortly.

Enquire Product